Henry James International Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Henry James International Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35,137	Closed	-$2.42M	–	157
2021 Q2	$2.42M	Sell	35,137 -233	-0.7%	-$17.8K	0.69%	42
2021 Q1	$2.73M	Buy	35,370 +16,190	+84%	+$1.49M	0.82%	38
2020 Q4	$1.9M	Sell	19,180 -6,196	-24%	-$758K	0.66%	47
2020 Q3	$3.6M	Sell	25,376 -1,095	-4%	-$183K	1.47%	22
2020 Q2	$5.22M	Buy	26,471 +1,464	+6%	+$303K	2.19%	11
2020 Q1	$4.9M	Buy	25,007 +1,296	+5%	+$279K	2.52%	10
2019 Q4	$4.9M	Buy	23,711 +3,147	+15%	+$582K	1.9%	18
2019 Q3	$3.14M	Sell	20,564 -70	-0.3%	-$11.5K	1.34%	24
2019 Q2	$2.66M	Sell	20,634 -85	-0.4%	-$10.1K	1.14%	29
2019 Q1	$2.44M	Buy	20,719 +740	+4%	+$74.6K	1.11%	29
2018 Q4	$1.83M	Sell	19,979 -30	-0.1%	-$3.04K	1.19%	31
2018 Q3	$2.25M	Buy	+20,009	New	+$2.11M	0.85%	31

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Henry James International Management's LKFT Position: Q3 2021 in Review

Henry James International Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2021, closing a stake of 35,137 shares — an estimated $2.42M sold.

Henry James International Management first reported a position in LKFT in Q3 2018 and held it in 12 quarters. The position peaked at $5.22M in Q2 2020. 81 funds tracked by Wall St. Rank hold LKFT as of Q3 2021.

Henry James International Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Henry James International Management sold 35,137 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2021, an estimated $2.42M.
Henry James International Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 12 quarters.
Henry James International Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.22M in Q2 2020.
81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2021.

Based on Henry James International Management's 13F filing for Q3 2021, filed 19 Oct 2021.